Common use of Research Programs Clause in Contracts

Research Programs. For each Collaboration Tumor Type, the Parties, via the JSC, shall: (a) promptly (but no later than sixty (60) days) following the Restatement Date (if not already approved prior to the Restatement Date), approve a written plan describing the research activities to be conducted by Arcturus to identify and optimize Collaboration Compounds for such Collaboration Tumor Type (each, a “Research Program”); and (b) consider and approve appropriate amendments and modifications to each such plan (each such plan, as so amended, a “Research Plan”). Prior to the Restatement Date, the Parties have agreed upon the initial Research Plan for the Research Program directed to Brain and Ovarian Neoplasms which initial Research Plan is deemed approved by the JSC hereunder. Upon JSC approval of the Research Plan for any other Collaboration Tumor Type, or upon JSC approval of any amendment or modification to any Research Plan, the JSC will attach such Research Plan, or such amendment or modification (as applicable), to the minutes of the JSC meeting at which the same is approved.

Appears in 2 contracts

Sources: Joint Venture, Research Collaboration and License Agreement (Arcturus Therapeutics Ltd.), Joint Venture, Research Collaboration and License Agreement (Arcturus Therapeutics Ltd.)